Medline Inc. (MDLN) Financial Statements

Executive TeamFinancials

Medline financial statements at a glance

Medline reported revenue of $28.43 billion for fiscal year 2025 (ended December 31, 2025). Net income was $1.16 billion, a net margin of 4.1%, and diluted earnings per share were -$0.01.

At the end of fiscal year 2025 it had total assets of $38.48 billion, total liabilities of $19.20 billion and shareholders' equity of $10.74 billion, with cash and short-term investments of $1.94 billion and total debt of $12.63 billion.

Its operations brought in $1.74 billion of cash; capital spending was $447.00 million, leaving free cash flow of $1.30 billion.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 4 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

MDLN logo

Medline Inc.

MDLNUnited States
USD (Local)

Income Statement

Annual • USD

Tax Effect of Unusual Items
-6.42M
Provision for Income Taxes
91.00M
Pre-tax Income
1.25B
Other Income Expense
-152.00M
Other Non-operating Income (expense)
-64.00M
Gain on Sale of Securities
-88.00M
Net Non Operating Interest Income Expense
-812.00M
Non-operating Interest Expense
812.00M
Operating Income
2.21B
Operating Expense
5.31B
Other Operating Expenses
78.00M
Depreciation Amortization Depletion
704.00M
Depreciation and amortization
704.00M
Amortization
704.00M
Amortization of Intangibles
704.00M
Selling General and Administrative
4.52B
Gross Profit
7.52B
Cost of Revenue
20.91B
Total Revenue
28.43B
Operating Revenue
28.43B
Tax Rate for Calcs
0.073
Normalized EBITDA
3.16B
Total Unusual Items
-88.00M
Total Unusual Items Excluding Goodwill
-88.00M
Net Income from Continuing Operation Net Minority Interest
1.16B
Reconciled Depreciation
1.01B
Reconciled Cost of Revenue
20.61B
EBITDA
3.07B
EBIT
2.06B
Net Interest Income
-812.00M
Interest Expense
812.00M
Normalized Income
1.24B
Net Income from Continuing and Discontinued Operation
1.16B
Total Expenses
26.22B
Total Operating Income as Reported
2.21B
Weighted Average Shares (diluted)
810.00M
Prev Year: 1.83B
YoY: -55.7%
Weighted Average Shares (basic)
810.00M
Prev Year: 1.83B
YoY: -55.7%
Diluted EPS
-0.01
Prev Year: 0.657
YoY: -101.5%
Basic EPS
-0.01
Prev Year: 0.657
YoY: -101.5%
Diluted NI Available to Com Stockholders
1.16B
Net Income Common Stockholders
1.16B
Net Income
1.16B
Noncontrolling Interests
2.00M
Prev Year: 0
Net Income Including Non-Controlling Interests
1.16B
Net Income from Continuing Operations
1.16B
Values in USD

Medline key figures by fiscal year

FY2025FY2024FY2023FY2022
Revenue$28.4B–––
Gross profit$7.5B–––
Operating income$2.2B–––
Net income$1.2B–––
Diluted EPS-$0.01$0.66$0.13-$0.01
Total assets$38.5B–––
Total liabilities$19.2B–––
Shareholders' equity$10.7B$16.5B$55.0M–
Cash and short-term investments$1.9B–––
Total debt$12.6B–––
Operating cash flow$1.7B–––
Capital spending$447.0M–$275.0M–
Free cash flow$1.3B–$1.4B–

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2022.

Questions and answers

What was Medline's revenue in fiscal year 2025?

$28.43 billion.

How much profit does Medline make?

Medline reported net income of $1.16 billion for fiscal year 2025 (4.1% of revenue); operating income was $2.21 billion.

How much cash and debt does Medline have?

At the end of fiscal year 2025: cash and short-term investments of $1.94 billion and total debt of $12.63 billion.

What is Medline's free cash flow?

$1.30 billion in fiscal year 2025 (operating cash flow of $1.74 billion minus capital spending of $447.00 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube